Biocept Inc. (BIOCQ) — Cash Flow-to-Debt Ratio
Biocept Inc. (BIOCQ) has a Cash Flow-to-Debt Ratio of -0.14x as of June 2023, meaning its operating cash flow of $-3.09 Million could theoretically repay 0% of its total liabilities ($21.81 Million) in one year. See BIOCQ FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biocept Inc. Cash Flow-to-Debt Ratio (2019–2022)
Historical debt coverage capacity for Biocept Inc. across 4 annual periods. Also explore net asset growth rate of Biocept Inc. to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Biocept Inc. (2019–2022)
Year-by-year debt coverage analysis for Biocept Inc.. For market capitalisation and broader financial context, see Biocept Inc. (BIOCQ) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -0.60x | $-13.29 Million | $22.01 Million | ▼ -475.3% |
| 2021 | 0.16x | $3.69 Million | $22.94 Million | ▲ +119.3% |
| 2020 | -0.83x | $-19.79 Million | $23.76 Million | ▲ +76.4% |
| 2019 | -3.53x | $-23.05 Million | $6.53 Million | — |